Yunnan Botanee Bio-Technology Group Co.LTD
SZSE:300957.SZ
72.28 (CNY) • At close October 26, 2023
Overview | Financials
Numbers are in millions (except for per share data and ratios) CNY.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|
| Revenue
| 5,735.865 | 5,522.168 | 5,013.874 | 4,022.403 | 2,636.488 | 1,943.746 | 1,240.49 | 798.044 |
| Cost of Revenue
| 1,506.203 | 1,441.392 | 1,243.047 | 965.167 | 626.06 | 384.514 | 233.742 | 149.422 |
| Gross Profit
| 4,229.662 | 4,080.776 | 3,770.827 | 3,057.236 | 2,010.429 | 1,559.231 | 1,006.748 | 648.622 |
| Gross Profit Ratio
| 0.737 | 0.739 | 0.752 | 0.76 | 0.763 | 0.802 | 0.812 | 0.813 |
| Reseach & Development Expenses
| 267.01 | 298.817 | 254.698 | 113.221 | 63.441 | 54.109 | 46.013 | 28.917 |
| General & Administrative Expenses
| 228.758 | 176.583 | 152.652 | 120.812 | -40.883 | -295.529 | -320.655 | -223.507 |
| Selling & Marketing Expenses
| 2,303.317 | 2,191.935 | 2,047.881 | 1,680.77 | 1,107.132 | 843.355 | 502.633 | 327.901 |
| SG&A
| 2,532.075 | 3,035.853 | 2,200.532 | 1,801.582 | 1,066.249 | 547.826 | 181.978 | 104.394 |
| Other Expenses
| 777.897 | -152.065 | 174.614 | 149.756 | 220.293 | 443.016 | -3.634 | 7.768 |
| Operating Expenses
| 3,605.144 | 3,202.802 | 2,629.844 | 2,064.559 | 1,349.984 | 1,044.952 | 685.9 | 457.296 |
| Operating Income
| 624.518 | 877.974 | 1,212.109 | 1,015.71 | 649.701 | 502.077 | 312.673 | 186.087 |
| Operating Income Ratio
| 0.109 | 0.159 | 0.242 | 0.253 | 0.246 | 0.258 | 0.252 | 0.233 |
| Total Other Income Expenses Net
| -16.119 | -9.155 | 1.756 | 2.166 | -1.862 | 0.165 | 0.516 | 0.329 |
| Income Before Tax
| 608.399 | 868.819 | 1,213.865 | 1,017.876 | 647.839 | 502.242 | 313.189 | 186.417 |
| Income Before Tax Ratio
| 0.106 | 0.157 | 0.242 | 0.253 | 0.246 | 0.258 | 0.252 | 0.234 |
| Income Tax Expense
| 113.606 | 109.607 | 163.448 | 153.814 | 104.084 | 89.18 | 50.267 | 31.011 |
| Net Income
| 503.054 | 756.795 | 1,051.332 | 862.923 | 543.508 | 411.945 | 260.527 | 153.631 |
| Net Income Ratio
| 0.088 | 0.137 | 0.21 | 0.215 | 0.206 | 0.212 | 0.21 | 0.193 |
| EPS
| 1.2 | 1.79 | 2.48 | 2.04 | 1.28 | 0.97 | 0.72 | 0.43 |
| EPS Diluted
| 1.2 | 1.79 | 2.48 | 2.04 | 1.28 | 0.97 | 0.72 | 0.43 |
| EBITDA
| 815.806 | 1,011.678 | 1,309.189 | 1,095.458 | 663.716 | 515.538 | 325.961 | 199.086 |
| EBITDA Ratio
| 0.142 | 0.183 | 0.261 | 0.272 | 0.252 | 0.265 | 0.263 | 0.249 |